T

Trince

12 employees

Trince is advancing cell-based science and therapeutics by facilitating the delivery of molecules into cells, both in vitro and ex vivo.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Genetics
Biopharma

Date founded

2014

Funding rounds raised

Total raised

$4.5M

from 2 investors over 2 rounds

T

Trince raised $4.5M on December 4, 2021

Investors: Qbic and Novalis_Fund

FAQ